TO EVALUATE THE USEFULNESS OF EPICARDIAL FAT THICKNESS AS A PARAMETER OF ABDOMINAL VISCERAL ADIPOSITY IN OBESE & NON-OBESE TYPE 2 DIABETES PATIENTS

Abstract

Background & Method: This study was done at Department of Endocrinology/General Medicine, Index Medical College Hospital & Research Centre, Indore, M.P. with an aim to Evaluate the Usefulness of Epicardial Fat Thickness as a parameter of Abdominal Visceral Adiposity in Obese & Non-Obese Type 2 Diabetes Patients.  FBS/PPBS done by GOD POD method IN Vitros “S”, FS machine, HBA1C Done by HPLC plus ion exchange resin. Lipid profile after overnight fasting of 12 hours blood collected in the morning about 5 ml and the serum centrifuged and kept for analysis. Serum cholesterol estimation: The CHOD-PAP method, enzymatic colorimetric test was used in Vitros “S”, FS machine.

Result: In our study, out of 150 patients maximum patients were in the age group of 51-60 years i.e. 65 (43.3%) with mean epicardial fat thickness and visceral fat thickness was 11.177 mm and 52.585mm, followed by 37 (24.7%) patients in 41-50 years of age group with mean epicardial fat thickness and visceral fat thickness 11.52 mm and 54.216 mm, followed by 35 patient (23.3) in 61-70 with mean epicardial fat thickness and visceral fat thickness 11.249 mm and 53.971mm and 13 patient (8.7) in 31-40 age group with mean epicardial fat thickness and visceral fat thickness 10.862 mm and 53.862 mm respectively.

Conclusion: Obesity is an independent risk factor for visceral adipose tissue deposition both in abdomen as well as in epicardial surface. It can be assumed that epicardial fat reflects the more rapid and massive visceral fat loss occur after a low calorie diet program and help to reduce cardio-metabolic risk and the development of metabolic syndrome and thus contribute to reduction in morbidity and mortality in type 2 diabetic obese and non-obese patient.

Keywords: Evaluate, EFT, Visceral & Adiposity.